Stratos Wealth Partners LTD. acquired a new stake in SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) in the third quarter, according to the company in its most recent filing with the SEC. The firm acquired 2,089 shares of the company’s stock, valued at approximately $101,000.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Advisors Preferred LLC bought a new position in SPDR S&P Pharmaceuticals ETF in the 3rd quarter valued at approximately $121,000. Cornerstone Wealth Management LLC bought a new position in SPDR S&P Pharmaceuticals ETF in the 3rd quarter valued at approximately $931,000. Oliver Luxxe Assets LLC bought a new position in SPDR S&P Pharmaceuticals ETF in the 3rd quarter valued at approximately $240,000. Nwam LLC bought a new position in SPDR S&P Pharmaceuticals ETF in the 3rd quarter valued at approximately $235,000. Finally, Citadel Advisors LLC raised its holdings in SPDR S&P Pharmaceuticals ETF by 29.7% in the 2nd quarter. Citadel Advisors LLC now owns 42,213 shares of the company’s stock valued at $1,816,000 after buying an additional 9,672 shares during the last quarter.

Shares of NYSEARCA XPH opened at $43.04 on Tuesday. SPDR S&P Pharmaceuticals ETF has a 1 year low of $38.71 and a 1 year high of $49.97.

TRADEMARK VIOLATION WARNING: “Stratos Wealth Partners LTD. Buys Shares of 2,089 SPDR S&P Pharmaceuticals ETF (XPH)” was first reported by Daily Political and is owned by of Daily Political. If you are reading this piece of content on another website, it was illegally copied and reposted in violation of U.S. & international copyright legislation. The original version of this piece of content can be accessed at https://www.dailypolitical.com/2018/11/20/stratos-wealth-partners-ltd-buys-shares-of-2089-spdr-sp-pharmaceuticals-etf-xph.html.

SPDR S&P Pharmaceuticals ETF Company Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Read More: What is cost of equity?

Want to see what other hedge funds are holding XPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH).

Institutional Ownership by Quarter for SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH)

Receive News & Ratings for SPDR S&P Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.